4.0
Aug 3, 2024
Current employee
Chicago, IL
Recommend
CEO approval
Business Outlook
Pros
It is a good place but wish the company does better in the future. We have fallen behind many other pharma that we were leading not that long ago
Cons
It is uncertain if we will have a massive boost to our company performance